TZ7-16813-92757
3 vaccinations
5 coded responses
22 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-15
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Fatigue or tirednessFree text: Injection site is warm to the touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-17
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-04-24
- 2021-05-01
- 2021-05-09
- 2021-05-15
- 2021-05-24
- 2021-07-10
- 2021-10-09
-
2021-11-08
Dose 2 — Pfizer-BioNTech
- 2022-04-10
-
2022-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-25
Survey response — day 21, dose 3MedDRA: COVID-19, Emergency care — Feeling: Fair · Be unable to work or attend schoolFree text: I got Covid in July 2022 that required prednisone and nbulizer treatments and a trip to the ER my pulse ox was 91% for over a weekMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Survey response — day 28, dose 3MedDRA: Paranasal sinus discomfort, Sputum discoloured, Upper-airway cough syndrome — Feeling: FairFree text: Sinus pressure yellow mucus increased post nasal dripMedDRA releases: 2024-11 · check-in free text available
- 2022-11-03
-
2022-11-10
Survey response — day 42, dose 3MedDRA: Sinusitis — Feeling: FairFree text: Sinus infection.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-29
Survey response — 3 months, dose 3MedDRA: Kidney infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Kidney infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-29
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-30
-
2023-01-04
Call successfulCompleted over the phone
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-08 | Pfizer-BioNTech | No |
| 3 | 2022-09-29 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site is warm to the touch
Release 12 — day 21, dose 3
Symptoms: I got Covid in July 2022 that required prednisone and nbulizer treatments and a trip to the ER my pulse ox was 91% for over a week
Release 12 — day 28, dose 3
Symptoms: Sinus pressure yellow mucus increased post nasal drip
Release 12 — day 42, dose 3
Symptoms: Sinus infection.
Release 12 — 3 months, dose 3
Symptoms: Kidney infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Kidney infection | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release